Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Type I Diabetes III: Clinical Manifestations

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Safety and glycemic outcomes of DBLG1 coupled to the DANA-i pump in adults and adolescents with type 1 diabetes mellitus. The SP8 trial.

Journal of endocrinological investigation·2025

Same author

Practical implementation of automated insulin delivery systems in 2025: A French position statement update.

Diabetes & metabolism·2025

Same author

Practical implementation of automated closed-loop insulin delivery: A French position statement.

Diabetes & metabolism·2020

Same author

Modeling the variability of insulin sensitivity for people with Type 1 Diabetes based on clinical data from an artificial pancreas study.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2020

Same author

Structural variability of collagen fibers in the calcareous axial rod of a sea pen.

Journal of morphology·2018

Same author

Prior automatic posture and activity identification improves physical activity energy expenditure prediction from hip-worn triaxial accelerometry.

Journal of applied physiology (Bethesda, Md. : 1985)·2017

Search research articles

Related Experiment Video

Updated: May 21, 2026

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy

Published on: July 14, 2023

Type 1 diabetes: dealing with physical activity.

S Franc¹, D Dardari, M Biedzinski

¹Department of Diabetes, Sud Francilien Hospital Centre, 116, boulevard Jean-Jaurès, 91100 Corbeil-Essonnes, France. sylvia.franc@free.fr

Diabetes & Metabolism

|June 19, 2012

Summary

This summary is machine-generated.

Type 1 diabetes patients using multiple insulin injections can now adjust insulin doses for physical activity using simple algorithms. These methods assess activity intensity to guide insulin reduction, improving glucose management.

More Related Videos

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

Static Strength Training Method for Type 2 Diabetic Mice

Static Strength Training Method for Type 2 Diabetic Mice

Published on: March 29, 2024

Related Experiment Videos

Last Updated: May 21, 2026

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy

Published on: July 14, 2023

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

Static Strength Training Method for Type 2 Diabetic Mice

Static Strength Training Method for Type 2 Diabetic Mice

Published on: March 29, 2024

Area of Science:

Endocrinology
Metabolic Diseases
Diabetes Management

Background:

Type 1 diabetes (T1D) management requires careful insulin dosing.
Patients using multiple insulin injections (MII) lack clear guidelines for adjusting insulin during physical activity (PA).
Existing algorithms for insulin adjustment during PA are not easily applicable for self-management.

Purpose of the Study:

To evaluate the effectiveness of simple algorithms for self-adjusting insulin doses in T1D patients during physical activity.
To determine if patient assessment of PA intensity can guide insulin dose modifications.

Main Methods:

A 4-month observational study involving 35 T1D patients using the Diabeo software system.
Algorithms proposed reducing mealtime insulin by 30% for moderate PA and 50% for intense PA.
For prolonged intense PA, a 50% insulin reduction plus extra carbohydrates was suggested.

Main Results:

Comparison of blood glucose (BG) profiles during PA (n=151) versus rest (n=3606) showed similar fasting BG.
A slight but significant increase in 2-hour postprandial BG (PPBG) was observed during PA, returning to baseline before the next meal.
The incidence of mild hypoglycemia was comparable whether or not PA was performed.

Conclusions:

Simple, patient-assessed PA intensity algorithms offer a pragmatic approach for insulin dose adjustment in T1D patients on MII.
This method empowers patients to proactively manage insulin needs during physical activity.
The findings suggest improved glucose control and reduced hypoglycemia risk with these self-management tools.